{"database": "openregs", "table": "documents", "rows": [["FDA-2020-D-1136-0064", "FDA", "FDA-2020-D-1136", "Resuming Normal Drug and Biologics Manufacturing Operations During the COVID-19 Public Health Emergency Guidance for Industry - \nSeptember 2020\nU.S. Department of Health and Human Services\nFood and Drug Administration\nCenter for Drug Evaluation and Research\nCenter for Biologics Evaluation and Research\nCenter for", "Other", "Guidance", "2020-09-10T04:00:00Z", 2020, 9, "2021-04-28T04:00:00Z", "2023-05-12T03:59:59Z", "2023-05-08T19:44:20Z", null, 0, 0, "0900006484abaf0f"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2020-D-1136-0064"], "units": {}, "query_ms": 16.124360961839557, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}